The international pharmaceutical in...

The international pharmaceutical industry is considered to be highly lucky having launched nearly 1,400 fresh molecular entities (NMEs--compounds that have not previously been made available as human therapeutics) from one side of to the other the last 30 years. (1) At at hand U.S. and European pharmaceutical companies are seen as the leaders in terminuss of new drug unfolding But Japanese companies have also made a steady contribution to global mix with drugs output, with their peak of succes occurring between 1992 and 19951 (Figure 1)

[FIGURE 1 OMITTED]

Rising charges but declining output

undivided of ...